Laboratorios Farmaceuticos ROVI 주식 주식분석 | 주식가격 | 뉴스 | ROVI.MC | ES0157261019 | A0M0GQ

날짜	Laboratorios Farmaceuticos ROVI 주식 가격
	0 undefined
	54.80 undefined
	54.65 undefined
	54.80 undefined
	54.50 undefined
	54.85 undefined
	54.35 undefined
	55.30 undefined
	55.30 undefined
	55.50 undefined
	55.25 undefined
	55.50 undefined
	66.30 undefined
	65.70 undefined
	65.25 undefined
	65.00 undefined
	65.55 undefined
	65.50 undefined
	64.70 undefined
	63.70 undefined
	63.10 undefined

날짜	Laboratorios Farmaceuticos ROVI 매출	Laboratorios Farmaceuticos ROVI EBIT	Laboratorios Farmaceuticos ROVI 이익
2028e	1.02 조. undefined	332.33 백만 undefined	244.59 백만 undefined
2027e	1.14 조. undefined	401.08 백만 undefined	306.88 백만 undefined
2026e	877.2 백만 undefined	262.88 백만 undefined	224.14 백만 undefined
2025e	748.7 백만 undefined	198.47 백만 undefined	169.93 백만 undefined
2024e	781.27 백만 undefined	199.96 백만 undefined	164.18 백만 undefined
2023	829.51 백만 undefined	220.25 백만 undefined	170.34 백만 undefined
2022	817.7 백만 undefined	255.85 백만 undefined	199.67 백만 undefined
2021	648.68 백만 undefined	183.07 백만 undefined	153.08 백만 undefined
2020	419.96 백만 undefined	78.77 백만 undefined	61.06 백만 undefined
2019	381.31 백만 undefined	43.18 백만 undefined	39.27 백만 undefined
2018	303.2 백만 undefined	17.46 백만 undefined	17.9 백만 undefined
2017	275.65 백만 undefined	19.01 백만 undefined	17.24 백만 undefined
2016	265.17 백만 undefined	28.3 백만 undefined	26.09 백만 undefined
2015	246.01 백만 undefined	21.84 백만 undefined	19.81 백만 undefined
2014	238.05 백만 undefined	27.43 백만 undefined	24.12 백만 undefined
2013	217.6 백만 undefined	25.4 백만 undefined	23 백만 undefined
2012	201.9 백만 undefined	21.7 백만 undefined	19.5 백만 undefined
2011	184.7 백만 undefined	19 백만 undefined	18.1 백만 undefined
2010	158.6 백만 undefined	26 백만 undefined	24.6 백만 undefined
2009	141.8 백만 undefined	25.5 백만 undefined	20.1 백만 undefined
2008	127.5 백만 undefined	28.3 백만 undefined	23.5 백만 undefined
2007	100.7 백만 undefined	18.4 백만 undefined	15 백만 undefined
2006	105 백만 undefined	13.4 백만 undefined	10.9 백만 undefined
2005	82.6 백만 undefined	3.3 백만 undefined	4.1 백만 undefined
2004	63.7 백만 undefined	3.5 백만 undefined	14.5 백만 undefined

	매출	EBIT	이익
2004	63.7 백만 EUR	3.5 백만 EUR	14.5 백만 EUR
2005	82.6 백만 EUR	3.3 백만 EUR	4.1 백만 EUR
2006	105 백만 EUR	13.4 백만 EUR	10.9 백만 EUR
2007	100.7 백만 EUR	18.4 백만 EUR	15 백만 EUR
2008	127.5 백만 EUR	28.3 백만 EUR	23.5 백만 EUR
2009	141.8 백만 EUR	25.5 백만 EUR	20.1 백만 EUR
2010	158.6 백만 EUR	26 백만 EUR	24.6 백만 EUR
2011	184.7 백만 EUR	19 백만 EUR	18.1 백만 EUR
2012	201.9 백만 EUR	21.7 백만 EUR	19.5 백만 EUR
2013	217.6 백만 EUR	25.4 백만 EUR	23 백만 EUR
2014	238.05 백만 EUR	27.43 백만 EUR	24.12 백만 EUR
2015	246.01 백만 EUR	21.84 백만 EUR	19.81 백만 EUR
2016	265.17 백만 EUR	28.3 백만 EUR	26.09 백만 EUR
2017	275.65 백만 EUR	19.01 백만 EUR	17.24 백만 EUR
2018	303.2 백만 EUR	17.46 백만 EUR	17.9 백만 EUR
2019	381.31 백만 EUR	43.18 백만 EUR	39.27 백만 EUR
2020	419.96 백만 EUR	78.77 백만 EUR	61.06 백만 EUR
2021	648.68 백만 EUR	183.07 백만 EUR	153.08 백만 EUR
2022	817.7 백만 EUR	255.85 백만 EUR	199.67 백만 EUR
2023	829.51 백만 EUR	220.25 백만 EUR	170.34 백만 EUR
2024e	781.27 백만 EUR	199.96 백만 EUR	164.18 백만 EUR
2025e	748.7 백만 EUR	198.47 백만 EUR	169.93 백만 EUR
2026e	877.2 백만 EUR	262.88 백만 EUR	224.14 백만 EUR
2027e	1.14 조. EUR	401.08 백만 EUR	306.88 백만 EUR
2028e	1.02 조. EUR	332.33 백만 EUR	244.59 백만 EUR

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

26.4	12.3	19.3	17.2	19.6	35.9	33.6	49.5	16.6	14.7	18.97	29.25	41.38	40.7	95.51	67.43	53.16	99.04	124.95	25.32
26.2	25.9	25.3	34.6	40.5	50.7	45.9	59.4	43.8	43.8	52.37	45.38	45.23	49.75	60.18	81.54	76.4	150.17	180.01	143.31
1.4	2.5	1.9	1.9	11.2	9.3	15.6	13	14.4	15.5	15.42	15.59	13.08	2.23	3.41	10.1	7.8	9.89	4.15	0
8.7	14	18.7	20.9	25.8	30.4	41.8	41.3	56.2	58.7	67.57	63.86	67.39	75.49	94.86	158.81	227.2	245.47	311.94	337.97
1.6	4.1	6.2	5.7	1.8	0	25	6	0	4.7	0	0	0	0	0.04	0	0.01	1.79	2.03	2.73
64.3	58.8	71.4	80.3	98.9	126.3	161.9	169.2	131	137.4	154.33	154.08	167.07	168.17	254	317.89	364.58	506.36	623.07	509.33
5.5	11.3	14	21.6	29.8	32.5	42.7	45.9	53.8	60.2	73.59	81.8	82.82	89.06	95.84	131.61	155.4	181.78	215.54	253.65
1.1	0.7	0	0	0	0	0	0	0	0	0	0	2.57	2.05	2.04	1.84	1.88	2.07	2.2	0.59
0	0	0	0.9	1.1	2.6	2.1	0.3	0.1	0.1	0.14	0.14	0.19	0.07	0.07	0.07	0.07	0.07	0.07	0.07
0	0	0	0.7	0.7	1	2.3	2.7	3.2	14.5	17.21	18.88	24.87	27.08	34.65	45.08	41.41	38.56	35.74	33.9
1.4	1.4	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
8.6	17.2	16.5	8.6	5.2	2.4	3.9	10	34.2	23.6	8.35	8.94	10.32	11.96	16.11	14.73	11.11	3.85	2.08	2.34
16.6	30.6	31.9	31.8	36.8	38.5	51	58.9	91.3	98.4	99.29	109.76	120.78	130.22	148.7	193.33	209.86	226.31	255.63	290.55
80.9	89.4	103.3	112.1	135.7	164.8	212.9	228.1	222.3	235.8	253.62	263.85	287.85	298.38	402.7	511.21	574.44	732.68	878.7	799.88

10.7	9.9	3.5	3	3	3	3	3	3	3	3	3	3	3	3.36	3.36	3.36	3.36	3.24	3.24
0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	87.64	87.64	87.64	87.64	87.64	87.64
30.2	34.4	37.9	48.9	72.2	85.4	103.1	112.9	125.5	142.2	158.28	169.9	189.11	197.09	205.28	241.73	302.89	446.1	456.7	556.19
0	0	0	0	-3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
40.9	45.2	41.4	51.9	71.3	88.4	106.1	115.9	128.5	145.2	161.28	172.9	192.11	200.09	296.28	332.73	393.89	537.1	547.57	647.06
19	21.5	27.1	29.1	28.7	23.8	30.3	33.5	32	34.4	46.6	36.98	50.22	42.13	47.88	68.77	63.45	97.41	128.48	107.59
0	0	0	0	0	3	3.8	3.7	3.1	4.4	4.01	4.64	4.75	4.43	5.18	5.26	4.56	5.47	6.48	7.6
7.1	10.4	13.2	5.4	1.2	6.2	8.7	10.1	10.8	11.1	7.23	7.46	8.5	10.45	16.83	20.1	49.78	81.12	146.23	71.47
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	5.5	5.8	8.8	9.4	9.3	8.4	4.27	10.15	12.97	16.21	17.64	12.57	5.1	6.4	12.7	13.19
26.1	31.9	40.3	34.5	35.4	38.8	51.6	56.7	55.2	58.3	62.12	59.23	76.44	73.22	87.51	106.71	122.89	190.39	293.89	199.84
0	0.4	2.5	9.6	22.6	26	43.1	41.2	29.1	22.6	32.03	32.63	20.83	27.03	16.59	72.1	68.42	66.75	59.44	52.24
4	1.5	1.6	0.6	0.6	1.5	1.6	3.6	3.3	2.6	1.82	1.34	1.64	1.44	1.24	1.08	0.93	0.78	0.68	1.52
10	10.5	17.7	15.4	8.6	11.4	12.4	12.5	8.4	7.9	6.88	5.86	5.53	5.01	9.88	8.93	8.5	3.79	3.32	2.79
14	12.4	21.8	25.6	31.8	38.9	57.1	57.3	40.8	33.1	40.73	39.84	28	33.47	27.72	82.12	77.85	71.31	63.44	56.55
40.1	44.3	62.1	60.1	67.2	77.7	108.7	114	96	91.4	102.85	99.06	104.44	106.7	115.23	188.83	200.74	261.7	357.32	256.39
81	89.5	103.5	112	138.5	166.1	214.8	229.9	224.5	236.6	264.13	271.96	296.55	306.79	411.51	521.55	594.62	798.8	904.9	903.45

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
17	3	14	19	28	24	25	18	20	24	25	20	27	17	16	41	72	182	257	220
1	1	1	0	1	2	3	4	5	6	8	9	11	11	12	18	19	21	22	24
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1	-6	-2	-13	-14	-11	6	-6	-6	-2	-13	0	9	-9	-20	-68	-47	-52	-43	-133
3	0	-3	-5	-2	-2	-14	-4	0	0	2	-1	-3	-1	0	0	1	-1	0	1
0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0
2	-1	2	0	7	2	2	1	2	2	3	1	3	0	3	8	6	23	43	40
22	0	10	1	12	13	21	12	19	29	23	29	45	18	8	-9	46	149	237	113
0	-4	-7	-11	-9	-5	-5	-8	-13	-24	-25	-19	-18	-19	-26	-40	-39	-40	-51	-55
-4	-13	-6	2	-8	0	-24	8	-39	-13	-8	-19	-16	-19	-26	-40	-39	-40	-57	-52
-4	-8	0	14	1	5	-18	16	-26	11	16	0	1	0	0	0	0	0	-5	3
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	7	9	4	4	8	3	-6	-8	2	5	-9	9	-9	25	-11	-4	-5	-12
0	0	0	0	-2	2	0	0	0	1	-1	-5	0	0	87	0	0	-36	-99	-81
0	0	3	0	-2	3	0	-5	-12	-13	-7	-7	-17	0	72	21	-21	-62	-154	-160
0	-1	-4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2
0	0	0	-9	-3	-4	-7	-8	-6	-6	-8	-8	-6	-9	-5	-4	-9	-21	-51	-69
17	-14	6	4	2	16	-2	15	-32	2	7	2	12	0	54	-28	-14	45	25	-99
22.21	-5.21	3.14	-10.58	2.92	8.04	15.61	4.33	5.89	5.14	-2.05	9.49	27.45	-1.91	-17.93	-49.57	7.18	108.5	186.21	58.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Laboratorios Farmaceuticos ROVI 브루토마진	Laboratorios Farmaceuticos ROVI 이익 마진	Laboratorios Farmaceuticos ROVI EBIT-마진	Laboratorios Farmaceuticos ROVI 이익 마진
2028e	59.35 %	32.58 %	23.98 %
2027e	59.35 %	35.03 %	26.8 %
2026e	59.35 %	29.97 %	25.55 %
2025e	59.35 %	26.51 %	22.7 %
2024e	59.35 %	25.59 %	21.01 %
2023	59.35 %	26.55 %	20.53 %
2022	63.55 %	31.29 %	24.42 %
2021	59.32 %	28.22 %	23.6 %
2020	57.46 %	18.76 %	14.54 %
2019	56.31 %	11.33 %	10.3 %
2018	57.58 %	5.76 %	5.9 %
2017	60.77 %	6.9 %	6.25 %
2016	57.75 %	10.67 %	9.84 %
2015	60.54 %	8.88 %	8.05 %
2014	60.27 %	11.52 %	10.13 %
2013	60.98 %	11.67 %	10.57 %
2012	62.61 %	10.75 %	9.66 %
2011	62.43 %	10.29 %	9.8 %
2010	60.4 %	16.39 %	15.51 %
2009	67.28 %	17.98 %	14.17 %
2008	72.31 %	22.2 %	18.43 %
2007	68.22 %	18.27 %	14.9 %
2006	71.81 %	12.76 %	10.38 %
2005	71.91 %	4 %	4.96 %
2004	68.6 %	5.49 %	22.76 %

	브루토마진	EBIT-마진	이익 마진
2004	68.6 %	5.49 %	22.76 %
2005	71.91 %	4 %	4.96 %
2006	71.81 %	12.76 %	10.38 %
2007	68.22 %	18.27 %	14.9 %
2008	72.31 %	22.2 %	18.43 %
2009	67.28 %	17.98 %	14.17 %
2010	60.4 %	16.39 %	15.51 %
2011	62.43 %	10.29 %	9.8 %
2012	62.61 %	10.75 %	9.66 %
2013	60.98 %	11.67 %	10.57 %
2014	60.27 %	11.52 %	10.13 %
2015	60.54 %	8.88 %	8.05 %
2016	57.75 %	10.67 %	9.84 %
2017	60.77 %	6.9 %	6.25 %
2018	57.58 %	5.76 %	5.9 %
2019	56.31 %	11.33 %	10.3 %
2020	57.46 %	18.76 %	14.54 %
2021	59.32 %	28.22 %	23.6 %
2022	63.55 %	31.29 %	24.42 %
2023	59.35 %	26.55 %	20.53 %
2024e	59.35 %	25.59 %	21.01 %
2025e	59.35 %	26.51 %	22.7 %
2026e	59.35 %	29.97 %	25.55 %
2027e	59.35 %	35.03 %	26.8 %
2028e	59.35 %	32.58 %	23.98 %

날짜	Laboratorios Farmaceuticos ROVI 주당 매출	Laboratorios Farmaceuticos ROVI EBIT 당 주식	Laboratorios Farmaceuticos ROVI 주당 이익
2028e	19.91 undefined	0 undefined	4.77 undefined
2027e	22.35 undefined	0 undefined	5.99 undefined
2026e	17.12 undefined	0 undefined	4.37 undefined
2025e	14.61 undefined	0 undefined	3.32 undefined
2024e	15.25 undefined	0 undefined	3.2 undefined
2023	15.59 undefined	4.14 undefined	3.2 undefined
2022	15.29 undefined	4.79 undefined	3.73 undefined
2021	11.71 undefined	3.3 undefined	2.76 undefined
2020	7.58 undefined	1.42 undefined	1.1 undefined
2019	6.91 undefined	0.78 undefined	0.71 undefined
2018	5.92 undefined	0.34 undefined	0.35 undefined
2017	5.6 undefined	0.39 undefined	0.35 undefined
2016	5.41 undefined	0.58 undefined	0.53 undefined
2015	4.97 undefined	0.44 undefined	0.4 undefined
2014	4.77 undefined	0.55 undefined	0.48 undefined
2013	4.37 undefined	0.51 undefined	0.46 undefined
2012	4.06 undefined	0.44 undefined	0.39 undefined
2011	3.72 undefined	0.38 undefined	0.36 undefined
2010	3.19 undefined	0.52 undefined	0.49 undefined
2009	2.86 undefined	0.51 undefined	0.41 undefined
2008	2.56 undefined	0.57 undefined	0.47 undefined
2007	2.01 undefined	0.37 undefined	0.3 undefined
2006	2.1 undefined	0.27 undefined	0.22 undefined
2005	1.65 undefined	0.07 undefined	0.08 undefined
2004	1.27 undefined	0.07 undefined	0.29 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	1.27 EUR	0.07 EUR	0.29 EUR
2005	1.65 EUR	0.07 EUR	0.08 EUR
2006	2.1 EUR	0.27 EUR	0.22 EUR
2007	2.01 EUR	0.37 EUR	0.3 EUR
2008	2.56 EUR	0.57 EUR	0.47 EUR
2009	2.86 EUR	0.51 EUR	0.41 EUR
2010	3.19 EUR	0.52 EUR	0.49 EUR
2011	3.72 EUR	0.38 EUR	0.36 EUR
2012	4.06 EUR	0.44 EUR	0.39 EUR
2013	4.37 EUR	0.51 EUR	0.46 EUR
2014	4.77 EUR	0.55 EUR	0.48 EUR
2015	4.97 EUR	0.44 EUR	0.4 EUR
2016	5.41 EUR	0.58 EUR	0.53 EUR
2017	5.6 EUR	0.39 EUR	0.35 EUR
2018	5.92 EUR	0.34 EUR	0.35 EUR
2019	6.91 EUR	0.78 EUR	0.71 EUR
2020	7.58 EUR	1.42 EUR	1.1 EUR
2021	11.71 EUR	3.3 EUR	2.76 EUR
2022	15.29 EUR	4.79 EUR	3.73 EUR
2023	15.59 EUR	4.14 EUR	3.2 EUR
2024e	15.25 EUR	0 EUR	3.2 EUR
2025e	14.61 EUR	0 EUR	3.32 EUR
2026e	17.12 EUR	0 EUR	4.37 EUR
2027e	22.35 EUR	0 EUR	5.99 EUR
2028e	19.91 EUR	0 EUR	4.77 EUR

	주식 수량
2004	50 백만 Aktien
2005	50 백만 Aktien
2006	50 백만 Aktien
2007	50 백만 Aktien
2008	49.9 백만 Aktien
2009	49.6 백만 Aktien
2010	49.7 백만 Aktien
2011	49.7 백만 Aktien
2012	49.7 백만 Aktien
2013	49.8 백만 Aktien
2014	49.89 백만 Aktien
2015	49.54 백만 Aktien
2016	49.03 백만 Aktien
2017	49.26 백만 Aktien
2018	51.22 백만 Aktien
2019	55.18 백만 Aktien
2020	55.39 백만 Aktien
2021	55.4 백만 Aktien
2022	53.47 백만 Aktien
2023	53.19 백만 Aktien
2024e	53.19 백만 Aktien
2025e	53.19 백만 Aktien
2026e	53.19 백만 Aktien
2027e	53.19 백만 Aktien
2028e	53.19 백만 Aktien

날짜	Laboratorios Farmaceuticos ROVI 배당금
2028e	1.69 undefined
2027e	1.69 undefined
2026e	1.69 undefined
2025e	1.69 undefined
2024e	1.69 undefined
2023	1.29 undefined
2022	0.96 undefined
2021	0.38 undefined
2020	0.18 undefined
2019	0.08 undefined
2018	0.12 undefined
2017	0.18 undefined
2016	0.14 undefined
2015	0.17 undefined
2014	0.16 undefined
2013	0.14 undefined
2012	0.13 undefined
2011	0.17 undefined
2010	0.14 undefined
2009	0.09 undefined
2008	0.08 undefined

	배당금	배당금 (추정)
2004	0 EUR	0 EUR
2005	0 EUR	0 EUR
2006	0 EUR	0 EUR
2007	0 EUR	0 EUR
2008	0.08 EUR	0 EUR
2009	0.09 EUR	0 EUR
2010	0.14 EUR	0 EUR
2011	0.17 EUR	0 EUR
2012	0.13 EUR	0 EUR
2013	0.14 EUR	0 EUR
2014	0.16 EUR	0 EUR
2015	0.17 EUR	0 EUR
2016	0.14 EUR	0 EUR
2017	0.18 EUR	0 EUR
2018	0.12 EUR	0 EUR
2019	0.08 EUR	0 EUR
2020	0.18 EUR	0 EUR
2021	0.38 EUR	0 EUR
2022	0.96 EUR	0 EUR
2023	1.29 EUR	0 EUR
2024e	0 EUR	1.69 EUR
2025e	0 EUR	1.69 EUR
2026e	0 EUR	1.69 EUR
2027e	0 EUR	1.69 EUR
2028e	0 EUR	1.69 EUR

날짜	Laboratorios Farmaceuticos ROVI 배당률
2028e	20.23 %
2027e	19.99 %
2026e	19.6 %
2025e	21.09 %
2024e	19.27 %
2023	18.42 %
2022	25.59 %
2021	13.8 %
2020	15.88 %
2019	11.21 %
2018	34.55 %
2017	52.29 %
2016	26.12 %
2015	42.26 %
2014	33.35 %
2013	29.7 %
2012	32.54 %
2011	47.8 %
2010	28.78 %
2009	21.1 %
2008	16.66 %
2007	18.42 %
2006	18.42 %
2005	18.42 %
2004	18.42 %

	배당률
2004	18.42 %
2005	18.42 %
2006	18.42 %
2007	18.42 %
2008	16.66 %
2009	21.1 %
2010	28.78 %
2011	47.8 %
2012	32.54 %
2013	29.7 %
2014	33.35 %
2015	42.26 %
2016	26.12 %
2017	52.29 %
2018	34.55 %
2019	11.21 %
2020	15.88 %
2021	13.8 %
2022	25.59 %
2023	18.42 %
2024e	19.27 %
2025e	21.09 %
2026e	19.6 %
2027e	19.99 %
2028e	20.23 %

EPS-예상치	EPS-실제	보고 분기
0.18	0.31 (69.39 %)	2020 Q3
0.14	0.28 (96.08 %)	2020 Q2
0.14	0.25 (75.07 %)	2020 Q1
0.08	0.16 (96.08 %)	2019 Q4
0.13	0.26 (96.08 %)	2019 Q3
0.09	0.17 (83.01 %)	2019 Q2
0.09	0.12 (38.41 %)	2019 Q1
0.01	0.04 (684.31 %)	2018 Q4
0.06	0.16 (161.44 %)	2018 Q3
0.13	0.01 (-92.46 %)	2018 Q2
-0.06	-0.04 (34.64 %)	2017 Q4
0.02	0.09 (336.27 %)	2016 Q4
0.11	0.13 (12.96 %)	2015 Q1
0.12	0.1 (-17.02 %)	2014 Q3
0.14	0.18 (31.68 %)	2014 Q2
0.17	0.12 (-29.54 %)	2014 Q1
0.2	0.09 (-56.37 %)	2013 Q4
0.15	0.1 (-34.62 %)	2013 Q3
0.36	0.28 (-22.01 %)	2013 Q2
0.08	0.06 (-26.47 %)	2012 Q4
0.11	0.07 (-34.02 %)	2012 Q3
0.1	0.16 (51.96 %)	2012 Q2
0.01	0.05 (670.49 %)	2011 Q4
0.09	0.06 (-38.88 %)	2011 Q3
0.06	0.16 (171.36 %)	2011 Q2
-0	0 (100 %)	2010 Q4
0.1	0.1 (4.28 %)	2010 Q1
0.09	0.06 (-32.4 %)	2009 Q4
0.14	0.2 (43.16 %)	2009 Q3
0.11	0.04 (-62.3 %)	2009 Q2
0.12	0.07 (-38.81 %)	2008 Q4
0.17	0.17 (5.33 %)	2008 Q3
0.12	0.11 (-6.33 %)	2008 Q2
0.14	0.12 (-14.52 %)	2008 Q1

%-지분	이름	주식	변경
58.18076 %	Norbel Invesrsiones, S.L.	29,811,821	0
5.05958 %	Indumenta Pueri, S.L.	2,592,530	-140,688
2.26568 %	Capital Research Global Investors	1,160,933	0
1.38190 %	T. Rowe Price International Ltd	708,085	-135,675
1.19650 %	The Vanguard Group, Inc.	613,088	-3,330
0.98071 %	Norges Bank Investment Management (NBIM)	502,518	-47,974
0.83601 %	INVESCO Asset Management Limited	428,371	-106,389
0.70659 %	RBC Global Asset Management (UK) Limited	362,059	72
0.70651 %	BNP Paribas Asset Management UK Limited	362,017	0
0.69477 %	Dimensional Fund Advisors, L.P.	355,999	0
0.51523 %	BlackRock Institutional Trust Company, N.A.	264,006	6,932
0.49351 %	ProfitlichSchmidlin AG	252,873	0
0.45120 %	Bestinver Gesti¿n S.A., S.G.I.I.C.	231,196	33,497
0.41902 %	Victory Capital Management Inc.	214,707	164
0.40581 %	BNP Paribas Asset Management Belgium S.A.	207,939	0
0.38205 %	Pictet Asset Management Ltd.	195,763	0
0.32894 %	Soci¿t¿ de Gestion Pr¿voir	168,550	0
0.29009 %	EDM Gestión S.A., S.G.I.I.C.	148,642	-20,859
0.25519 %	BNP Paribas Asset Management France SAS	130,761	0
0.24913 %	Valentum Asset Management SGIIC, S.A.	127,652	37,903
0.24887 %	Santa Luc¿a Asset Management S.G.I.I.C., S.A.U.	127,522	-1,009
0.23810 %	DNCA Investments	122,000	35,697
0.20297 %	Credit Mutuel Asset Management	104,000	27,500
0.19028 %	Mandatum Asset Management Ltd	97,500	97,500
0.17372 %	Sycomore Asset Management	89,014	0
0.16439 %	RBC Global Asset Management Inc.	84,234	0
0.16417 %	Degroof Petercam Asset Management	84,122	-58,053
0.14966 %	Goldman Sachs Asset Management, L.P.	76,685	71,530
0.14821 %	JPMorgan Asset Management U.K. Limited	75,942	-17,548
0.14247 %	Fourton Rahastoyhtiö Oy	73,000	0
0.14007 %	Santander Asset Management	71,770	-91,891
0.13149 %	Invesco Advisers, Inc.	67,378	28,688
0.11845 %	Polar Capital LLP	60,692	-22,068
0.11322 %	Renta 4 Gestora, S.G.I.I.C., S.A.	58,015	-8,577
0.10908 %	Bellevue Asset Management AG	55,895	-14,332
0.10775 %	Amundi Asset Management, SAS	55,211	-4,212
0.10716 %	BlackRock Advisors (UK) Limited	54,907	135
0.09758 %	Ruffer LLP	50,000	-32,000
0.09707 %	Mellon Investments Corporation	49,738	487
0.09482 %	Principal Global Investors (Equity)	48,585	48,585
0.09122 %	Fidelity International	46,743	-187
0.09069 %	Dimensional Fund Advisors, Ltd.	46,469	0
0.08849 %	BBVA Asset Management, S.A., S.G.I.I.C.	45,340	-33,942
0.08782 %	BPI Gest¿o de Activos - S.G.F.I.M., S.A.	45,000	45,000
0.08146 %	Allianz Global Investors GmbH	41,740	-28,680
0.08141 %	J. Chahine Capital	41,714	-2,541
0.08086 %	State Street Global Advisors (US)	41,431	0
0.08068 %	Federated Hermes Global Investment Management Corp.	41,342	0
0.07980 %	DWS Investment GmbH	40,891	1,137
0.07780 %	Charles Schwab Investment Management, Inc.	39,864	-13,762
0.07739 %	California Public Employees' Retirement System	39,657	-1,069
0.07582 %	Thrivent Asset Management, LLC	38,852	445
0.07416 %	Artemis Investment Management LLP	38,000	0
0.07412 %	California State Teachers Retirement System	37,980	2,411
0.07229 %	Quoniam Asset Management GmbH	37,040	0
0.06635 %	Mandarine Gestion	34,000	34,000
0.06528 %	Mapfre Inversi¿n Dos, S.G.I.I.C., S.A.	33,450	-3,200
0.06341 %	American Century Investment Management, Inc.	32,491	-58,551
0.06284 %	Portzamparc Gestion S.A.	32,200	0
0.05872 %	Bessemer Trust Company, N.A. (US)	30,090	5,238
0.05783 %	Fideuram Asset Management (Ireland) dac	29,633	-93
0.05713 %	F¿rsta AP-Fonden	29,274	29,274
0.05367 %	Fondita Rahastoyhtiö Oy	27,500	-8,000
0.05281 %	Montanaro Asset Management Limited	27,061	-3,500
0.05269 %	Rothschild & Co Asset Management Europe SCS	27,000	3,800
0.05224 %	Singular Asset Management SGIIC SA.	26,770	1,370
0.05168 %	Mediolanum International Funds Limited	26,479	0
0.04883 %	Mapfre Asset Management, SGIIC, S.A.	25,019	2,819
0.04877 %	AllianceBernstein L.P.	24,990	0
0.04870 %	Wellington Management Company, LLP	24,954	0
0.04064 %	Muza Gesti¿n De Activos, S.G.I.I.C., S.A.	20,826	0
0.03923 %	Caixabank Asset Management SGIIC, S.A.U.	20,102	-2,177
0.03865 %	T. Rowe Price Investment Management, Inc.	19,802	-510
0.03743 %	Banque Degroof Petercam N.V.	19,181	-6,000
0.03725 %	Trea Asset Management S.G.I.I.C., S.A.	19,089	-4,138
0.03673 %	First Trust Advisors L.P.	18,820	-315
0.03430 %	Federal Finance Gestion	17,574	-1,409
0.03343 %	Kutxabank Gestion, SGIIC, S.A.U.	17,132	0
0.03208 %	Grupo Catalana Occidente, S.A.	16,440	0
0.03172 %	Andbank Wealth Management, SGIIC, S.A.U.	16,252	2,050
0.03138 %	Nuveen LLC	16,078	0
0.03025 %	Ibercaja Gesti¿n S.G.I.I.C., S.A.	15,500	-5,000
0.03013 %	Geode Capital Management, L.L.C.	15,437	17
0.02927 %	Urquijo Gesti¿n, S.A., S.G.I.I.C., Sociedad Unipersonal	15,000	0
0.02768 %	UBS Asset Management (Switzerland)	14,182	345
0.02732 %	Deka Investment GmbH	14,000	-3,900
0.02703 %	Mirabaud Asset Management Limited	13,852	-27,592
0.02690 %	Fidelity Investment Luxembourg S.A.	13,785	-2,907
0.02510 %	AMUNDI IBERIA SGIIC SA	12,861	82
0.02450 %	Janus Henderson Investors	12,555	-1,758
0.02342 %	Banque Nationale de Belgique S.A.	12,000	0
0.02204 %	March Asset Management, S.G.I.I.C., S.A.U.	11,292	3,952
0.02198 %	SEI Investments Management Corporation	11,260	-12,368
0.02082 %	Mackenzie Investments	10,668	897
0.02048 %	Operadora Valmex de Fondos de Inversión, S.A. de C.V.	10,492	671
0.02000 %	Eika Kapitalforvaltning AS	10,249	0
0.01952 %	Cliens Asset Management AB	10,000	5,500
0.01949 %	Solventis A.V., S.A.	9,989	9,066
0.01932 %	Avantage Capital EAFI, SL	9,900	0
0.01893 %	Goldman Sachs Asset Management B.V.	9,700	0

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Merck & Co	공급업체고객	0,42	-0,60	-0,77	-0,60		0,25
Enervit SpA	공급업체고객	0,17	-0,01	-0,01	0,13	0,07	0,80
Moderna	공급업체고객	0,15	0,28	0,56	0,36	-0,48	0,60
Novartis	공급업체고객	0,15	0,64	-0,81	-0,68	-0,34
Elecnor	공급업체고객	-0,01	-0,67	-0,75	-0,44	0,19	0,62
Astellas Pharma	공급업체고객	-0,02	0,53	-0,44	-0,34	-0,03	0,68

What values and corporate philosophy does Laboratorios Farmaceuticos ROVI represent?

Laboratorios Farmaceuticos ROVI SA represents values of innovation, integrity, and excellence in the pharmaceutical industry. With a strong corporate philosophy centered on the development and manufacturing of innovative medicines and healthcare products, ROVI prioritizes patient well-being and strives for scientific advancement. The company's commitment to research and development, along with its focus on partnerships with healthcare professionals and organizations, enables ROVI to provide innovative solutions that improve patients' lives. By embracing a culture of responsibility, transparency, and ethical practices, Laboratorios Farmaceuticos ROVI SA aims to contribute to global healthcare and deliver value to its stakeholders.

In which countries and regions is Laboratorios Farmaceuticos ROVI primarily present?

Laboratorios Farmaceuticos ROVI SA is primarily present in Spain, where the company is based. Additionally, ROVI has a global presence, with its products and services being available in several other countries and regions around the world. These include various European countries such as Germany, France, Italy, Portugal, and the United Kingdom. Furthermore, ROVI has a significant presence in the Americas, including Mexico, Brazil, and Colombia. With its international reach, Laboratorios Farmaceuticos ROVI SA has established a strong presence in both European and American markets, catering to a wide range of customers and expanding its global footprint.

What significant milestones has the company Laboratorios Farmaceuticos ROVI achieved?

Laboratorios Farmaceuticos ROVI SA has achieved several significant milestones throughout its history. One noteworthy achievement is its development of innovative pharmaceutical products, including advanced drug delivery systems and therapeutic solutions. The company has also gained recognition for its expertise in biopharmaceutical manufacturing and has successfully established numerous strategic partnerships globally. Additionally, Laboratorios Farmaceuticos ROVI SA has demonstrated consistent growth and profitability, expanding its market presence and enhancing shareholder value. These achievements reflect the company's commitment to delivering high-quality healthcare solutions and driving advancements within the pharmaceutical industry.

What is the history and background of the company Laboratorios Farmaceuticos ROVI?

Laboratorios Farmaceuticos ROVI SA is a renowned pharmaceutical company with an impressive history and background. Established in 1946, ROVI SA has consistently focused on developing and manufacturing innovative healthcare solutions. With its headquarters in Madrid, Spain, the company operates in various therapeutic areas, including Special Focused Medicines, Biosimilars, and Active Pharmaceutical Ingredients (APIs). ROVI SA has a strong commitment to research and development, striving to improve patients' quality of life through cutting-edge treatments. Over the years, the company has gained recognition and trust from healthcare practitioners and patients alike, solidifying its position as a prominent player in the pharmaceutical industry.

Who are the main competitors of Laboratorios Farmaceuticos ROVI in the market?

The main competitors of Laboratorios Farmaceuticos ROVI SA in the market include pharmaceutical companies such as Novartis, Pfizer, Johnson & Johnson, and Sanofi.

In which industries is Laboratorios Farmaceuticos ROVI primarily active?

Laboratorios Farmaceuticos ROVI SA is primarily active in the pharmaceutical industry.

What is the business model of Laboratorios Farmaceuticos ROVI?

The business model of Laboratorios Farmaceuticos ROVI SA focuses on pharmaceutical research, development, manufacturing, and commercialization. The company operates in the specialty pharmaceuticals industry and specializes in the production of injectable pharmaceuticals and various other drugs. Laboratorios Farmaceuticos ROVI SA collaborates with international partners for the licensing and distribution of its products. With a strong emphasis on innovation and quality, the company aims to provide healthcare solutions through its unique product portfolio. Laboratorios Farmaceuticos ROVI SA actively pursues partnerships and collaborations to expand its market reach and continuously improve its product pipeline.

Laboratorios Farmaceuticos ROVI 2025의 P/E 비율은 얼마입니까?

Laboratorios Farmaceuticos ROVI에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Laboratorios Farmaceuticos ROVI 2025의 KUV는 얼마입니까?

Laboratorios Farmaceuticos ROVI에 대한 현재 KUV는 계산할 수 없습니다.

Laboratorios Farmaceuticos ROVI의 AlleAktien 품질 점수는 얼마인가요?

Laboratorios Farmaceuticos ROVI에 대한 AlleAktien 품질 점수는 9/10입니다.

Laboratorios Farmaceuticos ROVI 2025의 매출은 얼마인가요?

예상되는 Laboratorios Farmaceuticos ROVI 매출은 748.7 백만 EUR입니다.

Laboratorios Farmaceuticos ROVI 2025의 이익은 얼마인가요?

예상되는 Laboratorios Farmaceuticos ROVI 이익은 169.93 백만 EUR입니다.

Laboratorios Farmaceuticos ROVI은 무엇을 하나요?

Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the development and production of biotechnological drugs, vaccines, and generics. The company was founded in Spain in 1946 and has since built an impressive track record. Today, ROVI is a global player with customers in over 80 countries worldwide. ROVI operates in three business segments: Innovation, Generics, and Specialties. In the Innovation segment, the company focuses on biotechnological drugs and vaccines, with a particular emphasis on tissue repair, kidney and liver diseases, and immuno-oncology. The pipeline of Innovation includes a variety of innovative drugs in various stages of clinical development. A significant milestone for the company was the successful approval of Doria®, an inactivated SARS-CoV-2 vaccine for individuals aged 18 years and older. In the Generics segment, ROVI focuses on high-quality generics for various diseases. The company has strong partnerships worldwide, giving it access to a broad network of producers and suppliers. ROVI is an important supplier to the public health sector in many countries. The Specialties segment comprises different products, such as contrast agents for medical imaging, wound care, and non-surgical wrinkle treatment. ROVI's product range includes a variety of drugs and vaccines for different diseases and applications. Some of the most well-known products are Envarsus® for preventing transplant rejection in kidney or liver transplantations, Bemiparin as an anticoagulant for the prevention and treatment of thrombosis, and Hepacare® for the treatment of Hepatitis C, used in countries like Pakistan to reduce the spread of the disease. To meet the growing needs of the healthcare market, ROVI has invested in research and development. The company has expanded its research and development pipeline and works on developing innovative drugs and products. ROVI is also known for investing in partnerships. The company collaborates closely with other bio-pharmaceutical companies and research institutes to develop new drugs. These partnerships also open up new markets and provide access to new technologies. In summary, ROVI SA has been active as a strategic and influential company in the biopharmaceutical world. Investments in research and development, innovation, and partnerships have contributed to ROVI's recognition in the industry. With a wide network of producers and suppliers worldwide and customers in over 80 countries, ROVI is globally present and has established a strong position in the public health sector.

Laboratorios Farmaceuticos ROVI 배당금은 얼마입니까?

Laboratorios Farmaceuticos ROVI은(는) 연간 1번의 배당을 통해 0.96 EUR의 배당금을 지급합니다.

Laboratorios Farmaceuticos ROVI이 얼마나 자주 배당을 지급하나요?

Laboratorios Farmaceuticos ROVI는 연간 1번의 배당금을 지급합니다.

Laboratorios Farmaceuticos ROVI ISIN이 무엇입니까?

Laboratorios Farmaceuticos ROVI의 ISIN은 ES0157261019입니다.

Laboratorios Farmaceuticos ROVI WKN은 무엇인가요?

Laboratorios Farmaceuticos ROVI의 WKN은 A0M0GQ입니다.

Laboratorios Farmaceuticos ROVI 티커는 무엇인가요?

Laboratorios Farmaceuticos ROVI의 티커는 ROVI.MC입니다.

Laboratorios Farmaceuticos ROVI이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Laboratorios Farmaceuticos ROVI은(는) 1.29 EUR 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Laboratorios Farmaceuticos ROVI은(는) 1.69 EUR의 배당금을 지급할 것으로 예상됩니다.

Laboratorios Farmaceuticos ROVI의 배당 수익률은 얼마입니까?

Laboratorios Farmaceuticos ROVI의 현재 배당 수익률은 입니다.

Laboratorios Farmaceuticos ROVI의 배당금은 언제 지급되나요?

Laboratorios Farmaceuticos ROVI은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Laboratorios Farmaceuticos ROVI의 배당금은 얼마나 안전한가요?

Laboratorios Farmaceuticos ROVI은(는) 지난 21년 동안 매년 배당금을 지급했습니다.

Laboratorios Farmaceuticos ROVI의 배당금은 얼마입니까?

향후 12개월 동안 1.69 EUR의 배당금이 예상됩니다. 이는 배당수익률 3.09 %에 해당합니다.

Laboratorios Farmaceuticos ROVI이(가) 속해 있는 섹터는 어디인가요?

Laboratorios Farmaceuticos ROVI은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Laboratorios Farmaceuticos ROVI kaufen, um die vorherige Dividende zu erhalten?

Laboratorios Farmaceuticos ROVI의 마지막 배당금을 1.104 EUR만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Laboratorios Farmaceuticos ROVI의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Laboratorios Farmaceuticos ROVI의 2024년도 배당금은 얼마였습니까?

2024년에 Laboratorios Farmaceuticos ROVI는 1.294 EUR를 배당금으로 지급했습니다.

Laboratorios Farmaceuticos ROVI는 어떤 화폐로 배당금을 지급하나요?

Laboratorios Farmaceuticos ROVI의 배당금은 EUR에 지급됩니다.

Scope 1 - 직접 방출	6,693
스코프 2 - 구매한 에너지로부터의 간접적인 배출	616
Scope 3 - 가치 창출 체인 내의 간접 배출	10,352
총 CO₂ 배출량	7,309
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	53
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	Laboratorios Farmaceuticos ROVI 티커
BME	ROVI.MC
뒤셀도르프	41L.DU
프랑크푸르트	41L.F
LONDON	0ILL.L
LONDON STOCK EXCHANGE	0ILL.L
MADRID	ROVI.MC
뮌헨	41L.MU
PNK	LABFF
SIX	41L.SW

Laboratorios Farmaceuticos ROVI 티커	Laboratorios Farmaceuticos ROVI FIGI
ROVI:SM	BBG000QP0656
ROVI:SQ	BBG000QP07P2
ROVIE:TQ	BBG000QTYHG5
41L:GR	BBG000RL1HQ6
41L:GF	BBG000RL1J37
41L:GD	BBG000RL1JP3
41L:GS	BBG000RL1KB5
41L:GM	BBG000RL1KN2
41L:GB	BBG000RL1KS7
ROVI:EO	BBG000S7S7K5
ROVI:XE	BBG000S7S8W0
ROVI:XL	BBG000S7S930
ROVI:E1	BBG000S7SD13
ROVI:XT	BBG000S7SD86
ROVI:XW	BBG000S7SDJ4
ROVI:EU	BBG000S7SF45
ROVIE:S1	BBG003YRZY67
ROVIE:EB	BBG004LMQ7N0
ROVIE:IX	BBG004M0GNR9
ROVI:XV	BBG00591R8J9
ROVIE:B3	BBG006T6LWV3
ROVIE:L3	BBG006T9XNL5
ROVIE:PO	BBG008H0D7V9
ROVIE:BQ	BBG009L20CZ7
ROVIUSD:EO	BBG00BYDY092
ROVIUSD:XH	BBG00BYDY0D7
ROVIUSD:XF	BBG00BYDY0G4
ROVIUSD:XE	BBG00BYDY0J1
ROVIUSD:XJ	BBG00BYDY0K9
ROVIUSD:XL	BBG00BYDY0L8
ROVIUSD:XG	BBG00BYDY0M7
ROVIUSD:XO	BBG00BYDY0N6
ROVIUSD:XS	BBG00BYDY0S1
ROVIUSD:XA	BBG00BYDY0T0
ROVIUSD:E1	BBG00BYDY0V7
ROVIUSD:XT	BBG00BYDY0W6
ROVIUSD:XW	BBG00BYDY0X5
ROVIUSD:XU	BBG00BYDY0Y4
ROVIUSD:XV	BBG00BYDY0Z3
ROVIUSD:EU	BBG00BYDY190
41L:QT	BBG00DB57214
ROVI:XM	BBG00J9VW763
0ILL:LN	BBG00JHVW8P1
ROVI:XX	BBG00JN7NXK7
ROVIUSD:XX	BBG00JN8GMY2
41L:SW	BBG00LVDP5T0
41L:BW	BBG00LVDP609
ROVIE:T1	BBG00NLK4HY2
ROVIE:I2	BBG00NQCS7B6
ROVI:X2	BBG00Q6RC3Z8
41L:TH	BBG00QJ7DNZ3
ROVIN:MM	BBG00RPL6PP7
ROVIN:MU	BBG00RPL6PR5
ROVIE:L1	BBG00Y92RXZ1
LABFF:US	BBG00YD8S1B8
LABFF:PQ	BBG00YD8S1R1
LABFF:UV	BBG00YD8S1S0
ROVIE:S4	BBG00YJ80ZQ1
ROVIGBP:XS	BBG00ZLHDFK1
ROVIGBP:XH	BBG00ZLHDFN8
ROVIGBP:XF	BBG00ZLHDFR4
ROVIGBP:XE	BBG00ZLHDFV9
ROVIGBP:XL	BBG00ZLHDFX7
ROVIGBP:XG	BBG00ZLHDFY6
ROVIGBP:XO	BBG00ZLHDFZ5
ROVIGBP:XA	BBG00ZLHDG38
ROVIGBP:XT	BBG00ZLHDG56
ROVIGBP:XW	BBG00ZLHDG65
ROVIGBP:XU	BBG00ZLHDG74
ROVIGBP:XV	BBG00ZLHDGB9
ROVIGBP:XM	BBG00ZLHDGC8
ROVIGBP:EU	BBG00ZLHDGL8
41L:GZ	BBG012DS4VG8
ROVIE:QX	BBG0146TT3C9
ROVIE:QE	BBG0146TTCL9
41L:LA	BBG018H8PJV2
41L:LU	BBG018J2BL25

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
0.06	0.08	0.11	0.1	0.13	0.14	0.16	0.18	0.2	0.22	0.24	0.25	0.27	0.28	0.3	0.38	0.42	0.65	0.82	0.83	0.78	0.75	0.88	1.14	1.02
-	30.16	28.05	-4.76	27.00	11.02	12.06	16.46	9.24	7.96	9.68	3.36	7.72	3.77	10.18	25.74	9.97	54.65	26.08	1.47	-5.79	-4.23	17.25	30.44	-10.84
68.25	71.95	71.43	68.00	72.44	67.38	60.13	62.50	62.69	60.83	60.08	60.16	57.74	60.73	57.43	56.17	57.52	59.26	63.53	59.35	63.00	65.78	56.10	43.01	48.24
43	59	75	68	92	95	95	115	126	132	143	148	153	167	174	214	241	384	519	492	0	0	0	0	0
14	4	10	15	23	20	24	18	19	23	24	19	26	17	17	39	61	153	199	170	164	169	224	306	244
-	-71.43	150.00	50.00	53.33	-13.04	20.00	-25.00	5.56	21.05	4.35	-20.83	36.84	-34.62	-	129.41	56.41	150.82	30.07	-14.57	-3.53	3.05	32.54	36.61	-20.26
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
50	50	50	50	49.9	49.6	49.7	49.7	49.7	49.8	49.89	49.54	49.03	49.26	51.22	55.18	55.39	55.4	53.47	53.19	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커ROVI.MC

ISINES0157261019

WKNA0M0GQ

Laboratorios Farmaceuticos ROVI 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Laboratorios Farmaceuticos ROVI 주가 이력

Laboratorios Farmaceuticos ROVI 주식 매출, EBIT, 이익 ES0157261019 · A0M0GQ

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Laboratorios Farmaceuticos ROVI 매출, 이익 및 EBIT 역사

Laboratorios Farmaceuticos ROVI 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Laboratorios Farmaceuticos ROVI 주식 마진 ES0157261019 · A0M0GQ

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Laboratorios Farmaceuticos ROVI 마진 역사

Laboratorios Farmaceuticos ROVI 주식 매출, EBIT, 주당 순이익 ES0157261019 · A0M0GQ

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Laboratorios Farmaceuticos ROVI 매출, 이익 및 EBIT 주당 역사

Laboratorios Farmaceuticos ROVI 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

Laboratorios Farmaceuticos ROVI Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Laboratorios Farmaceuticos ROVI 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Laboratorios Farmaceuticos ROVI 주식 수량 ES0157261019 · A0M0GQ

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Laboratorios Farmaceuticos ROVI 주식 배당금 ES0157261019 · A0M0GQ

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Laboratorios Farmaceuticos ROVI 배당금 내역

Laboratorios Farmaceuticos ROVI 주식 배당률 ES0157261019 · A0M0GQ

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

티커
ROVI.MC

ISIN
ES0157261019

WKN
A0M0GQ